Reference
Mahto A, et al. The right choice? secukinumab in co-existing axial disease and multiple sclerosis. Rheumatology 58 (Suppl. 3): iii90-iii91 abstr. 120, Apr 2019. Available from: URL: http://doi.org/10.1093/rheumatology/kez108.028 [abstract] - United Kingdom
Rights and permissions
About this article
Cite this article
Adalimumab. Reactions Weekly 1763, 20 (2019). https://doi.org/10.1007/s40278-019-65112-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-019-65112-y